Steven Perrin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Eledon Pharmaceuticals, Inc. (ELDN)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Eledon Pharmaceuticals, Inc. (ELDN) | President and Chief Scientific Officer | $484,919 | $1,696,284 |
| 2024 | Eledon Pharmaceuticals, Inc. (ELDN) | President and Chief Scientific Officer | $455,258 | $4,571,222 |
| 2023 | Eledon Pharmaceuticals, Inc. (ELDN) | President and Chief Scientific Officer | $437,439 | $1,540,583 |
| 2022 | Eledon Pharmaceuticals, Inc. (ELDN) | President and Chief Scientific Officer | $417,052 | $1,049,577 |
| 2021 | Eledon Pharmaceuticals, Inc. (ELDN) | President and Chief Scientific Officer | $402,923 | $566,813 |
| 2020 | Eledon Pharmaceuticals, Inc. (ELDN) | Ph.D.^(^^3)^ President and Chief Scientific Officer | $122,308 | $3,113,055 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.